NO20022532L - Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser - Google Patents

Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser

Info

Publication number
NO20022532L
NO20022532L NO20022532A NO20022532A NO20022532L NO 20022532 L NO20022532 L NO 20022532L NO 20022532 A NO20022532 A NO 20022532A NO 20022532 A NO20022532 A NO 20022532A NO 20022532 L NO20022532 L NO 20022532L
Authority
NO
Norway
Prior art keywords
nucleic acids
synthesis
preparation
new compounds
environmental test
Prior art date
Application number
NO20022532A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022532D0 (no
Inventor
Pascale Jeannin
Jean-Luc Pernodet
Michel Guerineau
Pascal Simonet
Sophie Courtois
Cormela Cappellano
Francois Francou
Alain Raynal
Maria Ball
Guennadi Sezonov
Karine Tuphile
Aasa Frostegaard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9915032A external-priority patent/FR2801609B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20022532D0 publication Critical patent/NO20022532D0/no
Publication of NO20022532L publication Critical patent/NO20022532L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20022532A 1999-11-29 2002-05-28 Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser NO20022532L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9915032A FR2801609B1 (fr) 1999-11-29 1999-11-29 Procede d'obtention d'acides nucleiques a partir d'un echantillon de l'environnement, acides nucleiques ainsi obtenus et leur application a la synthese de nouveaux composes
US20980000P 2000-06-07 2000-06-07
PCT/FR2000/003311 WO2001040497A2 (fr) 1999-11-29 2000-11-27 Procede d'obtention d'acides nucleiques a partir d'un echantillon de l'environnement

Publications (2)

Publication Number Publication Date
NO20022532D0 NO20022532D0 (no) 2002-05-28
NO20022532L true NO20022532L (no) 2002-06-26

Family

ID=26235170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022532A NO20022532L (no) 1999-11-29 2002-05-28 Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser

Country Status (9)

Country Link
EP (1) EP1268764A2 (fr)
JP (1) JP2003520578A (fr)
KR (1) KR20020060242A (fr)
AU (2) AU781961B2 (fr)
BR (1) BR0015993A (fr)
CA (1) CA2393041A1 (fr)
IL (1) IL149846A0 (fr)
NO (1) NO20022532L (fr)
WO (1) WO2001040497A2 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010047029A1 (en) * 2000-04-26 2001-11-29 Handelsman Jo E. Triaryl cation antibiotics from environmental DNA
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US20040121311A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in livestock
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
FR2834997B1 (fr) * 2002-01-21 2004-03-19 Evialis Procede de detection de champignons producteurs d'ochratoxine a ou de citrinine
EP1386966A1 (fr) 2002-07-24 2004-02-04 Libragen Méthode pour l'expresssion de l'ADN environmental dans des cellules hôtes
WO2004018673A2 (fr) * 2002-08-20 2004-03-04 B.R.A.I.N. Biotechnology Research And Information Network Ag Isolement et clonage de l'adn d'organismes non cultives
EP1905833B1 (fr) 2002-10-08 2015-08-12 Aventis Pharma S.A. Polypeptides impliqués dans la biosynthèse des spiramycines, séquences nucléotidiques codant ces polypeptides et leurs applications
JP2006516193A (ja) 2002-12-06 2006-06-29 アイシス・ファーマシューティカルス・インコーポレーテッド ヒトおよび動物における病原体の迅速な同定方法
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8394945B2 (en) 2003-09-11 2013-03-12 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
WO2005073377A1 (fr) * 2004-01-28 2005-08-11 Toudai Tlo, Ltd. Methode d’extraction de l’adn depuis un echantillon environnemental
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
EP1766659A4 (fr) 2004-05-24 2009-09-30 Ibis Biosciences Inc Spectrometrie de masse a filtration ionique selective par seuillage numerique
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
WO2005121336A1 (fr) * 2004-06-08 2005-12-22 Toagosei Co., Ltd. Procédé de purification de l'adn environnemental et procédé de dépistage efficace du gène codant la protéine appartenant à l'adn environnemental
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (fr) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Procedes pour l'identification rapide d'organismes recombinants
WO2006094238A2 (fr) 2005-03-03 2006-09-08 Isis Pharmaceuticals, Inc. Compositions utilisees pour identifier des virus secondaires
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
WO2007014045A2 (fr) 2005-07-21 2007-02-01 Isis Pharmaceuticals, Inc. Procede pour l'identification et la quantification rapide de variants d'acide nucleique
CA2663029C (fr) 2006-09-14 2016-07-19 Ibis Biosciences, Inc. Procede d'amplification ciblee de genome entier pour l'identification d'agents pathogenes
JP5680304B2 (ja) 2007-02-23 2015-03-04 アイビス バイオサイエンシズ インコーポレイティッド 迅速な法医学的ｄｎａ分析法
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
WO2010033599A2 (fr) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Cartouches de mélange, postes de mélange et kits, systèmes et procédés associés
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
US8148163B2 (en) 2008-09-16 2012-04-03 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
EP2358908B1 (fr) 2008-11-14 2014-01-08 Gen-Probe Incorporated Compositions et procédés pour la détection d'acide nucléique de campylobacter
EP2396803A4 (fr) 2009-02-12 2016-10-26 Ibis Biosciences Inc Ensembles sonde d'ionisation
US9194877B2 (en) 2009-07-17 2015-11-24 Ibis Biosciences, Inc. Systems for bioagent indentification
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
EP3225695A1 (fr) 2009-10-15 2017-10-04 Ibis Biosciences, Inc. Amplification de déplacement multiple
EP2325312A1 (fr) * 2009-11-19 2011-05-25 Qiagen GmbH Procédé d'enrichissement sélectif et d'isolement de microbes et en outre, optionellement, d'acides nucléiques viraux

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900677A (en) * 1986-09-26 1990-02-13 E. I. Du Pont De Nemours And Company Process for rapid isolation of high molecular weight DNA
CA2219136A1 (fr) * 1995-04-24 1996-10-31 Chromaxome Corp. Procedes de generation et de criblage de nouvelles voies metaboliques
US6261842B1 (en) * 1997-10-23 2001-07-17 Wisconsin Alumni Research Foundation Microorganism genomics, compositions and methods related thereto
EP1090113A1 (fr) * 1998-06-23 2001-04-11 Biosearch Italia S.p.A. Procedes de transfert de la capacite de production d'un produit naturel dans un hote de production approprie

Also Published As

Publication number Publication date
IL149846A0 (en) 2002-11-10
WO2001040497A3 (fr) 2002-10-17
AU781961B2 (en) 2005-06-23
EP1268764A2 (fr) 2003-01-02
KR20020060242A (ko) 2002-07-16
NO20022532D0 (no) 2002-05-28
BR0015993A (pt) 2002-08-06
WO2001040497A2 (fr) 2001-06-07
AU2005211587A1 (en) 2005-10-13
CA2393041A1 (fr) 2001-06-07
JP2003520578A (ja) 2003-07-08
AU2179101A (en) 2001-06-12

Similar Documents

Publication Publication Date Title
NO20022532L (no) Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser
AU2001245945A1 (en) Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
DE69635744D1 (de) Modifizierte Nukleinsäuresonden
DE60007257D1 (de) Verfahren zur Herstellung von Cucurbituril Derivaten
NO20022171D0 (no) Fremgangsmåte for syntetisering av nukleinsyre
DE10084445T1 (de) Vorrichtung zur Herstellung von Kapseln
FR2802647B1 (fr) Sonde pour aeronef
DE60215476D1 (de) Vorrichtung zur prüfung der auflösung von produkten
ID22863A (id) Metoda untuk memproduksi bahan asam nukleat
NO20014957D0 (no) Fremgangsmåte for fremstilling av aminplatinakomplekser
DE69914233D1 (de) Fahrzeug-Radargerät zum korrekten Entdecken von Gegenständen
ATE440944T1 (de) Vorrichtung zur vorbereitung von zellen
DE50002810D1 (de) Vorrichtung zur Bestimmung der Achslage von Hohlzylindern
DE60045451D1 (de) Vorrichtung zur Herstellung von Mikroarrays
DE50101833D1 (de) Verfahren zur Feiunverteilung von Pigmenten
DE50012558D1 (de) Verfahren zur Herstellung von Pigmentgranulaten
DE59900703D1 (de) Verfahren zur Herstellung von Chinacridonpigmenten
DE60016555D1 (de) Verfahren zur herstellung von copolymerisierten polyestern
NO20024060D0 (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
DE60042518D1 (de) Verfahren zur speicherprüfung
NO20000933L (no) Fremgangsmõte for fremstilling av polymer
DE69921587D1 (de) Verfahren zur Herstellung von hochchromatischen Perylenpigmenten
DE60005440D1 (de) Anordnung zur Herstellung von Matrixen von Proben
NO993913D0 (no) Fremgangsmåte for fremstilling av eprosartan
DE60119458D1 (de) Vorrichtung zur Feststellung der genetischen Sequenz von Biopolymeren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application